Zembrace® SymTouch® is indicated for the acute treatment of migraine with or without aura in adults.
Limitations of Use: Use only if a clear diagnosis of migraine has been established. Not indicated for the preventive treatment of migraine.
Zembrace® SymTouch® is contraindicated in patients with a history of hemiplegic or basilar migraine. This is not the only contraindication for Zembrace® SymTouch®.
Patients pay $0 per prescription*
Learn more about the Platinum Pass® savings card.Patient savings card
*Restrictions apply. Maximum of eight single-use injections per month. Medicare, Medicaid, and other state and federal health care program patients are not eligible.
Committed to providing more
As Upsher-Smith Laboratories, LLC, celebrates a century of serving patients, we take pride in providing attentive customer service, having strong industry relationships and being dedicated to uninterrupted supply.
Zembrace® SymTouch® continues our commitment to ensure you have a variety of medication options that can address the unique needs of migraine patients.